Eli Lilly Stock: Is $934 Still Cheap After a 56% Revenue Surge?
Eli Lilly reported Q1 2026 revenue growth of 56% year-over-year and immediately raised full-year 2026 guidance by $2 billion. The stock jumped. Most i…
metabolic health
Eli Lilly reported Q1 2026 revenue growth of 56% year-over-year and immediately raised full-year 2026 guidance by $2 billion. The stock jumped. Most i…